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Abstract
Background: The aim of this study was to establish and validate a practical method to disperse
nanoparticles in physiological solutions for biological in vitro and in vivo studies.
Results: TiO2 (rutile) dispersions were prepared in distilled water, PBS, or RPMI 1640 cell culture
medium. Different ultrasound energies, various dispersion stabilizers (human, bovine, and mouse serum
albumin, Tween 80, and mouse serum), various concentrations of stabilizers, and different sequences of
preparation steps were applied. The size distribution of dispersed nanoparticles was analyzed by dynamic
light scattering and zeta potential was measured using phase analysis light scattering. Nanoparticle size was
also verified by transmission electron microscopy. A specific ultrasound energy of 4.2 × 105 kJ/m3 was
sufficient to disaggregate TiO2 (rutile) nanoparticles, whereas higher energy input did not further improve
size reduction. The optimal sequence was first to sonicate the nanoparticles in water, then to add
dispersion stabilizers, and finally to add buffered salt solution to the dispersion. The formation of coarse
TiO2 (rutile) agglomerates in PBS or RPMI was prevented by addition of 1.5 mg/ml of human, bovine or
mouse serum albumin, or mouse serum. The required concentration of albumin to stabilize the
nanoparticle dispersion depended on the concentration of the nanoparticles in the dispersion. TiO2 (rutile)
particle dispersions at a concentration lower than 0.2 mg/ml could be stabilized by the addition of 1.5 mg/
ml albumin. TiO2 (rutile) particle dispersions prepared by this method were stable for up to at least 1
week. This method was suitable for preparing dispersions without coarse agglomerates (average diameter
< 290 nm) from nanosized TiO2 (rutile), ZnO, Ag, SiOx, SWNT, MWNT, and diesel SRM2975 particulate
matter.
Conclusion: The optimized dispersion method presented here appears to be effective and practicable for
preparing dispersions of nanoparticles in physiological solutions without creating coarse agglomerates.
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In recent years, there has been a dramatic increase in
research, technology, and production of nanoparticles.
Nanoparticles are defined as particles with lengths rang-
ing from 1 to 100 nanometers in two or three dimensions
[1]. These nanoscaled particles have physico-chemical
properties different from those of bulk material and, thus,
offer opportunities for the development of new applica-
tions. Some of these engineered nanoparticles are already
in use in a diverse array of applications including medi-
cine, food, clothes, personal care products, information
technology, and construction materials, resulting in a
wide range of exposure scenarios. Therefore, it has
become important to determine the potential hazards of
nanoparticles on human health. [2-4]
Nanoparticles can come in contact with the human body
through inhalation but also through ingestion, dermal
deposition, or by medical applications through injection
[5]. Nanoparticles having entered the body through inha-
lation can translocate into the systemic circulation, reach
various remote organs, and affect their function [6].
For investigations of the in vivo effects of nanoparticles in
the circulation and for measuring the effects of nanoparti-
cles on different types of cells in vitro, nanoparticles have
to be dispersed in physiological solutions. However, par-
ticles in solutions with physiological salt concentrations
and pH values form micrometer-sized coarse agglomer-
ates [7-9]. Coarse agglomerates of nanoparticles have
been shown to exert different biological effects as com-
pared to well-dispersed nanoparticles [9-12]. Therefore,
investigating the biological effects of nanoscaled particles
with dispersions containing coarse agglomerates is not
appropriate. Previously, different methods have been
published on how to avoid the formation of coarse
agglomerates of nanoparticles dispersed in physiological
solutions. The importance of the correct ultrasound
energy as well as the use of dispersion stabilizers was
emphasized for the optimal deagglomeration of nanopar-
ticles [13]. Pulmonary surfactant, Tween, bronchoalveolar
lavage fluid, albumin, or serum were used as dispersion
stabilizers in physiological solutions [8,9,11]. Sonication
preceding the addition of a dispersion stabilizer to the
nanoparticle dispersion has been shown to be more effec-
tive than sonication afterwards [7]. However, most of
these studies have investigated only one aspect of the par-
ticle dispersion method or tested only one nanoparticle
type. For practical use in nanotoxicology experiments, a
complete method including all these aspects and working
on a wide range of different types of nanoparticles is nec-
essary.
Therefore, the aim of our study was to systematically ana-
lyze the importance of these aspects for the preparation of
nanoparticles and to set up an optimized nanoparticle
dispersion method for in vitro and in vivo studies. For this
purpose, we prepared different nanoparticle dispersions,
measured the size and zeta potential of the dispersions,
and analyzed the samples with transmission electron
microscopy. We tested different ultrasound energy levels,
distinct dispersion stabilizers (human, bovine, mouse
albumin, Tween 80, and mouse serum), various disper-
sion stabilizer and nanoparticle concentrations, and dif-
ferent sequences of preparation steps. We also tested our
method on a broad range of different types of nanoparti-
cles and measured the stability of the dispersion over
time.
Results
Measurement of polystyrene beads
The accuracy of size distribution and zeta potential meas-
urements of spherical particles was verified by measuring
60–65-nm polystyrene beads with different surface
charges. The size measurements demonstrated almost
identical results to those reported by the manufacturer.
Amine particles had a positive and carboxyl as well as
unmodified particles a negative zeta potential (Tab. 1).
Ultrasound energy
The effects of different ultrasound energies were tested on
TiO2 (rutile) suspensions in distilled water. A specific
ultrasound energy of 4.2 × 105 kJ/m3 (power consump-
tion: 7 W, 1 mL dispersion, 60 sec sonication) was suffi-
cient to disaggregate TiO2 (rutile) nanoparticles as
indicated by the reduction of the particle diameter from
527.6 ± 34.2 to 159.7 ± 2.3 nm (Fig. 1) and of the poly-
dispersity index (PdI, describes the width of the particle
size distribution) from 0.434 ± 0.086 to 0.166 ± 0.015
(data not shown). Higher energy input did not further
improve size reduction (Fig. 1).
Sequence of preparation steps
Different sequences of preparation steps of particle disper-
sions were assessed on TiO2 (rutile) (Fig. 2). TiO2 (rutile)
dispersed in phosphate buffered saline (PBS) had a higher
average diameter (912.1 ± 47.5 nm) and a greater PdI
(0.509 ± 0.017) than when dispersed in distilled water.
Human serum albumin (HSA) or Tween 80 added to the
TiO2 (rutile) dispersion without previous sonication did
not reduce the particle diameter in PBS. However, the
TiO2 (rutile) particle diameter was reduced in PBS when
HSA or Tween 80 was added to the dispersion after soni-
cation. In the case of HSA, the diameter of TiO2 (rutile)
particles was further reduced when the stabilizer was
added prior to addition of PBS. Best results were obtained
with HSA as dispersion stabilizer when we first sonicated
the TiO2 (rutile) nanoparticles in distilled water, then
added the dispersion stabilizer, and at the end added buff-
ered salt solution to the dispersion (average diameter =Page 2 of 14
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Particle Average diameter (nm) PdI Zeta Potential (mV)
TiO2rutile – Sigma
DI H2O no US 502 ± 34 0.434 ± 0.086 -44.2 ± 0.3
DI H2O 160 ± 2 0.166 ± 0.015 -40.9 ± 3
PBS 641 ± 69 0.263 ± 0.022 -19.5 ± 6.3
PBS, HSA 186 ± 10 0.212 ± 0.03 -8.8 ± 0.9
PBS, Tween 578 ± 132 0.248 ± 0.017 -13.3 ± 4.4
PBS, mserum 175 ± 5 0.270 ± 0.046 -10.7 ± 1.5
Diesel – SRM 2975
DI H2O no US 347 ± 21 0.397 ± 0.047 -45.2 ± 2.7
DI H2O 144 ± 1 0.132 ± 0.009 -48.4 ± 1.7
PBS 684 ± 284 0.249 ± 0.064 -32.0 ± 2.8
PBS, HSA 163 ± 3 0.152 ± 0.008 9.6 ± 0.6
PBS, Tween 151 ± 1 0.143 ± 0.012 -7.0 ± 0.2
PBS, mserum 168 ± 13 0.209 ± 0.033 -9.2 ± 1.4
Silver
DI H2O no US 403 ± 125 0.455 ± 0.039 -20.1 ± 3.9
DI H2O 161 ± 12 0.338 ± 0.055 -29.8 ± 0.3
PBS 223 ± 8 0.343 ± 0.026 -24.5 ± 3.1
PBS, HSA 172 ± 22 0.343 ± 0.018 -11.3 ± 0.3
PBS, Tween 194 ± 23 0.368 ± 0.014 -9.8 ± 1.9
PBS, mserum 158 ± 5 0.305 ± 0.063 -11.0 ± 0.6
TiO2anatase
DI H2O no US 1169 ± 48 0.462 ± 0.02 13.8 ± 2.1
DI H2O 517 ± 60 0.431 ± 0.055 -18.7 ± 0.4
PBS 890 ± 230 0.369 ± 0.077 -23.0 ± 1.7
PBS, HSA 521 ± 25 0.475 ± 0.023 -9.6 ± 1.1
PBS, Tween 818 ± 11 0.358 ± 0.029 -14.0 ± 2.5
PBS, mserum 574 ± 92 0.474 ± 0.111 -10.7 ± 1.1
ZnO
DI H2O no US 1298 ± 252 0.721 ± 0.072 10.6 ± 2.0
DI H2O 278 ± 72 0.414 ± 0.086 -29.4 ± 6.0
PBS 517 ± 174 0.445 ± 0.053 -29.3 ± 2.8
PBS, HSA 267 ± 6 0.288 ± 0.059 -11.6 ± 0.6
PBS, Tween 457 ± 135 0.360 ± 0.041 -14.6 ± 7.3
PBS, mserum 190 ± 8 0.544 ± 0.103 -7.7 ± 1.1
SiOx
DI H2O no US 1121 ± 304 0.593 ± 0.014 -33.4 ± 1.8
DI H2O 370 ± 49 0.488 ± 0.047 -21.1 ± 19.8
PBS 852 ± 267 0.617 ± 0.025 -14.5 ± 0.2
PBS, HSA 251 ± 27 0.880 ± 0.107 -10.4 ± 0.7
PBS, Tween 398 ± 51 0.532 ± 0.040 -3.7 ± 0.4
PBS, mserum 132 ± 49 0.497 ± 0.192 -11.1 ± 0.6
SWNT
DI H2O no US 689 ± 111 0.569 ± 0.100 -7.0 ± 7.6
DI H2O 372 ± 59 0.560 ± 0.076 -23.1 ± 10.4
PBS 977 ± 46 0.526 ± 0.131 -2.6 ± 2.3
PBS, HSA 285 ± 79 0.605 ± 0.143 -10.1 ± 0.7
PBS, Tween 291 ± 89 0.531 ± 0.103 -8.5 ± 3.3
PBS, mserum 115 ± 51 0.666 ± 0.132 -7.7 ± 1.6
MWNT
DI H2O no US 309 ± 48 0.304 ± 0.027 -2.7 ± 2.2
DI H2O 262 ± 101 0.397 ± 0.048 -22.5 ± 19.2Page 3 of 14
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tion of HSA prior to the addition of PBS prevented the
TiO2 (rutile) particles deagglomerated by sonication from
reagglomeration (Fig. 3). Interestingly, the diameter of
TiO2 (rutile) particles was slightly but significantly ele-
vated after HSA addition (from 159.7 ± 2.3 to 174.2 ± 2.2,
Fig. 3). This dispersion protocol also worked well when
RPMI 1640 cell culture medium was used as a dispersion
medium. Similar results where obtained using bovine
PBS 486 ± 173 0.424 ± 0.079 -19.6 ± 5.8
PBS, HSA 269 ± 56 0.406 ± 0.027 -9.7 ± 1.1
PBS, Tween 206 ± 13 0.292 ± 0.037 -4.8 ± 0.5
PBS, mserum 166 ± 10 0.415 ± 0.006 -7.8 ± 0.4
Plain polystyrene beads
DI H2O no US 67 ± 0.4 0.030 ± 0.004 -57.0 ± 5.3
PBS no US 73 ± 7 0.135 ± 0.068 -24.8 ± 5.7
Carboxyl modified polystyrene beads
DI H2O no US 60 ± 0.3 0.046 ± 0.021 -56.7 ± 0.3
PBS no US 58 ± 0.9 0.057 ± 0.018 -32.5 ± 2.5
Amine modified polystyrene beads
DI H2O no US 68 ± 0.5 0.062 ± 0.035 59.7 ± 4.9
PBS no US 86 ± 8 0.204 ± 0.029 19.0 ± 3.4
Nanoparticles were prepared in distilled water at a concentration of 0.02 mg/ml with (DI H2O) or without (DI H2O no US) sonication. For other 
measurements, nanoparticles were prepared in distilled water at a concentration of 0.02 mg/ml by sonication and addition of human serum albumin 
(PBS, HSA), Tween 80 (PBS, Tween), mouse serum (PBS, mserum) or distilled water (PBS) previous to addition of PBS. The measurements were 
made in triplicate. The average value and the standard deviation of the measurements are shown.
Table 1: Size and zeta potential of different type of nanoparticles. (Continued)
Effect of intensity of sonication on TiO2 (rutile) particle sizeFigure 1
Effect of intensity of sonication on TiO2 (rutile) parti-
cle size. TiO2 (rutile) dispersed in distilled water at a con-
centration of 0.02 mg/ml was sonicated with different specific 
energies, and the average of the hydrodynamic diameter of 
the particles was measured. The experiments were carried 
out in triplicates (*, p < 0.05).
Role of the sequence of preparation stepsFigure 2
Role of the sequence of preparation steps. TiO2 (rutile) 
dispersed in distilled water at a concentration of 0.02 mg/ml 
was sonicated with 4.2 × 105 kJ/m3 specific energy (US) or 
not sonicated (no US). Tween 80 0.1% (T), HSA 1.5 mg/ml 
(A) or distilled water (W) was given to the dispersion before 
(disp, PBS) or after (PBS, disp) addition of concentrated PBS. 
The average hydrodynamic diameter of the particles was 
measured (n = 4; *, p < 0.05 vs. dispersion in distilled water 
(W) without sonication (no US), #, p < 0.05 vs. dispersion in 
distilled water (W) with sonication (US), § p < 0.05).Page 4 of 14
(page number not for citation purposes)
Particle and Fibre Toxicology 2008, 5:14 http://www.particleandfibretoxicology.com/content/5/1/14serum albumin (BSA), mouse serum albumin (MSA), or
mouse serum as dispersion stabilizers (Fig. 4).
Albumin and nanoparticle concentration
To optimize the HSA concentration for stabilization of
dispersions, we prepared dispersions with different HSA
or TiO2 (rutile) concentrations. When changing HSA con-
centration at a constant TiO2 (rutile) concentration (0.02
mg/ml), we found that a HSA concentration between
0.015 mg/ml and 15 mg/ml prevented the formation of
coarse TiO2 (rutile) agglomerates. However, at a HSA con-
centration of 0.0015 mg/ml, the TiO2 (rutile) average
diameter and the PdI value were increased (Fig. 5 and Fig.
6). At a HSA concentration of 15 mg/ml, the average
diameter of TiO2 (rutile) particles was slightly decreased.
This decrease is not the result of a real change in the TiO2
(rutile) particle size, but the consequence of the presence
of particles with a diameter of 7.1 ± 0.1 nm (data not
shown) in the dispersion. The presence of these particles,
corresponding to free HSA molecules, causes a shift of the
average diameter. The presence of the two types of parti-
cles with different diameters (TiO2 and free HSA mole-
cules) in the dispersion can also be seen in the strong
increase of the PdI.
Next, we prepared dispersions with different TiO2 (rutile)
concentrations, but the same HSA (1.5 mg/ml) concentra-
tion. We found that HSA prevented the formation of
coarse agglomerates at TiO2 (rutile) concentrations rang-
ing from 0.002 to 0.2 mg/ml. As in the highest HSA con-
centration, the presence of particles with about 7 nm
caused a shift in the average diameter at the lowest TiO2
(rutile) concentration. At a TiO2 (rutile) concentration of
2 mg/ml, the average diameter and the PdI value were
increased. However, this increase in particle size could be
Size distribution by volume of a TiO2 (rutile) dispersion measured af er each preparation stepFigure 3
Size distribution by volume of a TiO2 (rutile) disper-
sion measured after each preparation step. TiO2 
(rutile) was dispersed in distilled water and sonicated (red), 
then HSA (blue) and finally concentrated PBS (green) was 
given to the dispersion. TiO2 (rutile) was also prepared on 
the same way but without HSA (black).
Albumin from different species and serum as dispersion sta-bi izerFig e 4
Albumin from different species and serum as disper-
sion stabilizer. TiO2 (rutile) dispersed in distilled water at a 
concentration of 0.02 mg/ml was sonicated, and HSA, MSA, 
BSA or mouse serum was given to the dispersion before the 
addition of concentrated PBS. The average hydrodynamic 
diameter of the particles was measured. The experiments 
were carried out in triplicates (*, p < 0.05 vs. dispersion 
without albumin in PBS; #, p < 0.05 vs. dispersion without 
albumin in RPMI).
TiO2 (rutile) particle size in dispersions with different HSA concentrationsF gure 5
TiO2 (rutile) particle size in dispersions with different 
HSA concentrations. TiO2 (rutile) dispersed in distilled 
water at a concentration of 0.02 mg/ml was sonicated and 
HSA at concentrations ranging from 0.0015 to 15 mg/ml was 
given to the dispersion prior to addition of concentrated 
PBS. The average hydrodynamic diameter of the particles 
was measured. The experiments were carried out in tripli-
cates (*, p < 0.05 vs. dispersion with 0.0015 mg/ml HSA).Page 5 of 14
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sion by 10 times (Fig. 7 and 8).
Stability
The stability of the TiO2 (rutile) dispersions prepared with
1.5 mg/ml HSA was determined over a time period of one
week (Fig. 9). During this time period, the TiO2 (rutile)
PBS dispersions prepared with HSA remained stable with-
out coarse agglomerates, whereas in dispersions without
HSA the average diameter and the PdI values were contin-
ually increasing and approaching a plateau at 24 hours.
Different type of nanoparticles
To test the applicability of our optimized method for
other nanoparticles, we prepared and measured TiO2
(anatase), ZnO, SWNT, MWNT, Silver, SiOx, and nano-
sized diesel particulate matter using HSA, Tween 80, or
mouse serum as dispersion stabilizers (Tab. 1). In all dis-
persions, the average diameter of the particles was greater
then the size of the primary particles, indicating the pres-
ence of some agglomerates. For all nanoparticles tested,
the addition of HSA, Tween 80, or mouse serum resulted
in a decreased average diameter. With HSA as dispersion
stabilizer, the average diameter of TiO2 (rutile), ZnO,
SWNT, MWNT, Silver, SiOx, and diesel nanoparticles was
below 290 nm. For TiO2 (anatase) particles, our method
was less effective as indicated by a higher average diameter
of the particles. In dispersions of SWNT, MWNT, and
SiOxnanoparticles, the PdI value was rather high.
Zeta-potential
All particles had a negative zeta potential in distilled water
after sonication (Table 1). Interestingly, ZnO and TiO2
(anatase) had a positive zeta-potential upon dispersion in
distilled water and became negative after sonication. The
particles were less negative when prepared with HSA,
Tween 80, or serum in PBS. TiO2 (rutile) prepared with
HSA in RPMI cell culture medium had a positive zeta
potential.
Transmission electron microscopy
To visualize nanoparticles in dispersions, we used trans-
mission electron microscopy (TEM). Similarly to the
dynamic light scattering measurements, TEM images
showed smaller nanoparticle agglomerates in dispersions
prepared with the addition of HSA or mouse serum as sta-
bilizers (Fig. 10, 11, 12). In the case of TiO2 (rutile) disper-
sions prepared with HSA, we measured the particle size
with an image analyzing software. The mean particle size
was 134 ± 71 nm.
Polydispersity index of TiO2 (rutile) in dispersions with dif-ferent HSA concentrationsFigure 6
Polydispersity index of TiO2 (rutile) in dispersions 
with different HSA concentrations. TiO2 (rutile) dis-
persed in distilled water at a concentration of 0.02 mg/ml 
was sonicated and HSA at concentrations ranging from 
0.0015 to 15 mg/ml were given to the dispersion prior to 
addition of concentrated PBS. Polydispersity index (PdI) of 
the particles was measured. The experiments were carried 
out in triplicates (*, p < 0.05 vs. dispersion with 0.0015 mg/ml 
HSA).
TiO2 (rutile) particle size in dispersions with different TiO2 concentrationsF gure 7
TiO2 (rutile) particle size in dispersions with different 
TiO2 concentrations. TiO2 (rutile) dispersed in distilled 
water at concentrations ranging from 0.002 to 2 mg/ml was 
sonicated and 1.5 mg/ml HSA was given to the dispersion 
before adding concentrated PBS to the dispersion. TiO2 
(rutile) dispersions at a concentration of 2 mg/ml were also 
prepared in the same way but with addition of 10 times more 
(15 mg/ml) HSA (hatched bar). The average hydrodynamic 
diameter of the particles was measured. The experiments 
were carried out in triplicates (*, p < 0.05 vs. dispersion with 
2 mg/ml TiO2 (rutile)).Page 6 of 14
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The aim of our study was to establish a method for the
preparation of stable nanoparticle dispersions, i.e. disper-
sions without coarse agglomerates in physiological solu-
tions. The stability of particle dispersions depends on the
balance between attractive and repulsive forces between
the particles (DLVO theory)[14]. In principle, there are
two ways to prepare stable dispersions: electrostatic and
steric stabilization. With electrostatic stabilization, the
zeta potential of the particles provides the repulsive force.
In practice, if the zeta potential of the particles is higher
than 30 mV or lower than -30 mV the dispersion is stable.
The zeta potential of the particles, however, strongly
depends on the pH and the electrolyte concentration of
the dispersion [14]. At physiological pH and electrolyte
concentration, the zeta potential of the particles is not
high enough to stabilize the dispersion, and the nanopar-
ticles form coarse agglomerates as it has been shown in
this as well as in previous studies [7-9]. Therefore, steric
stabilization is used for nanoparticle dispersion stabiliza-
tion in physiological solutions, where a stabilizer is added
to the dispersion adsorbing onto the particle surfaces and
preventing them from coming close to one another [15].
This strategy has been shown to be beneficial, and addi-
tion of different stabilizers has been demonstrated to
decrease the formation of coarse agglomerates and to
improve the stability of dispersions [8,9,11]. In our study,
we intended to optimize the factors that may influence
the effectiveness of steric stabilization, such as sonication,
sequence of preparation steps, and concentration of the
stabilizer.
To analyze the effectiveness of steric stabilization, i.e
measure the size of agglomerates in the dispersion, we
used dynamic light scattering that is a reliable technique
for measuring particle size and size distribution of dis-
persed spherical nanomaterials [15]. Moreover, we meas-
ured the zeta potential of the particles and visualized the
dispersed particles using transmission electron micros-
copy.
First, we measured the effect of different sonication ener-
gies. The result of sonication, e.g. particle size reduction,
depends on the applied energy per volume of the disper-
sion (specific energy) [16,17]. We found that after rapid
initial size reduction, a further increase in the specific
energy did not lead to a further reduction of the particle
size. Thus, a specific energy of 4.2 × 105 kJ/m3 was optimal
for deagglomerating the nanoparticles. Our findings con-
firm previous observations by Mandzy et al [13].
In a next set of experiments, we analyzed the optimal
sequence of particle preparation. The best sequence of dis-
persion preparation was when we first sonicated the nan-
Polydispersity index of TiO2 (rutile) dispersions with differ-ent T O2 conce trati nsFigure 8
Polydispersity index of TiO2 (rutile) dispersions with 
different TiO2 concentrations. TiO2 (rutile) dispersed in 
distilled water at concentrations ranging from 0.002 to 2 mg/
ml was sonicated and 1.5 mg/ml HSA was given to the disper-
sion before adding concentrated PBS to the dispersion. TiO2 
(rutile) dispersions at a concentration of 2 mg/ml were also 
prepared in the same way but with addition of 10 times more 
(15 mg/ml) HSA (hatched bar). Polydispersity index (PdI) of 
the particles was measured. The experiments were carried 
out in triplicates (*, p < 0.05 vs. dispersion with 2 mg/ml TiO2 
(rutile)).
Stability of TiO2 (rutile) dispersionFigure 9
Stability of TiO2 (rutile) dispersion. TiO2 (rutile) disper-
sions were prepared in distilled water at a concentration of 
0.02 mg/ml with (closed circles) or without (open circles) 
addition of HSA before giving concentrated PBS to the dis-
persion. The average hydrodynamic diameter of the particles 
was measured at different time points for up to one week. 
The experiments were carried out in triplicates (*, p < 0.05, 
dispersions with vs. without HSA at the same time point).Page 7 of 14
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PBS to the dispersion. With this dispersion sequence,
addition of HSA molecules after sonication prevents the
particles from the reagglomeration process caused by the
pH and ionic strength of PBS. Similar results were pub-
lished for the preparation of dispersions of C60 nanopar-
ticles [7]. The stabilizing effect of albumin was found to
be species-independent as the particles in the dispersions
with HSA, MSA, and BSA had comparable average diame-
ters and were medium-independent since HSA worked in
PBS as well as in RPMI cell culture medium.
When HSA molecules are added to the nanoparticles, they
adhere to the surface of the particles as indicated by a sig-
nificant increase in the average diameter of the particles.
This finding is in agreement with the prevailing opinion
about the formation of a "nanoparticle-protein corona"
upon incubation of nanoparticles with proteins [18].
Interestingly, in our measurements, the difference of aver-
age particle size between dispersions with and without
HSA was 14.5 nm, consistent with approximately twice
the diameter of one HSA molecule (7.1 ± 0.1 nm, our
measurement with DLS). These data suggest that the HSA
molecules may completely cover the nanoparticles. This
finding is corroborated by data from Lindman et al [19]
who found, using isothermal titration calorimetry tech-
nique, that particles with a diameter larger than 120 nm
are covered with a dense monolayer of proteins.
To further characterize the particle-albumin interaction,
we prepared dispersions with different particle and albu-
min concentrations. At a TiO2 (rutile) concentration of
0.02 mg/ml, HSA in a concentration higher than 0.015
mg/ml prevented the formation of coarse agglomerates.
With the elevation of the HSA concentration in the disper-
sion, the average diameter of the particles increases in a
concentration-dependent manner, obviously because the
albumin layer on the particles was getting thicker. Further
increase of the HSA concentration to 15 mg/ml results in
saturation of the particle surfaces and the amount of free
Electron microscopy of titanium dioxide nanoparticlesFigu e 10
Electron microscopy of titanium dioxide nanoparticles. Electron microscopic image at 100,000 times magnification 
(950 × 950 nm) from TiO2 (rutile) and TiO2 (anatase) nanoparticle dispersions prepared in distilled water at a concentration of 
0.02 mg/ml without stabilizer (PBS) or with addition of human serum albumin (+HSA) or mouse serum (+Serum) before giving 
concentrated PBS to the dispersion.Page 8 of 14
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ble. The lowest HSA/TiO2 (rutile) concentration ratio at
which the particles are covered with HSA and the disper-
sion is stable was 0.75 (the calculated HSA/TiO2 (rutile)
surface area ratio was 595). In this dispersion, there are
~33000 HSA molecules per each TiO2 (rutile) particle.
This number is ~7 times higher than calculated to be nec-
essary for a 100% HSA coverage of 200 nm spherical par-
ticles (4650 HSA molecules/particle) [19]. When we
increase the TiO2 (rutile) concentration 10-fold and use
the same HSA concentration, the number of HSA mole-
cules is not high enough to completely cover TiO2 (rutile)
particles and may not be sufficient to protect against
agglomeration of particles. Consistent with this theory,
Electron microscopy of zinc oxide, silicon oxide and silver nanoparticlesFigu e 11
Electron microscopy of zinc oxide, silicon oxide and silver nanoparticles. Electron microscopic image at 100,000 
times magnification (950 × 950 nm) from ZnO, SiOx and silver nanoparticle dispersions prepared in distilled water at a concen-
tration of 0.02 mg/ml without stabilizer (PBS) or with addition of human serum albumin (+HSA) or mouse serum (+Serum) 
before giving concentrated PBS to the dispersion.Page 9 of 14
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ever, when we increased the TiO2 (rutile) and HSA con-
centrations equally (10-fold), letting the HSA/TiO2
(rutile) surface area ratio unchanged, the dispersion
stayed stable. These data suggest that the required amount
of stabilizer depends on the total surface area of the parti-
cles in the dispersion. According to the measurements
with different TiO2 (rutile) concentrations, we choose 1.5
mg/ml HSA for our optimized method because this HSA
concentration prevented the formation of coarse agglom-
erates in a concentration range that might be relevant for
nanotoxicologic studies (0.002 mg/ml – 0.2 mg/ml).
Electron microscopy of nanotubes and diesel particlesFigu e 12
Electron microscopy of nanotubes and diesel particles. Electron microscopic image at 100,000 times magnification (950 
× 950 nm) from SWNT, MWNT and diesel (SRM 2975) particle dispersions prepared in distilled water at a concentration of 
0.02 mg/ml without stabilizer (PBS) or with addition of mouse serum (+Serum) or human serum albumin (+HSA) before giving 
concentrated PBS to the dispersion.Page 10 of 14
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serum to 1 ml dispersion) sufficient to achieve the albu-
min concentration similar to the dispersions prepared
with HSA, it also prevented the formation of coarse
agglomerates in TiO2 (rutile) dispersions (0.02 mg/ml).
This amount of serum contains abundant proteins to sat-
urate the particle surfaces as it has been reported that ~100
μl plasma saturates 1 mg 200 nm particles [20], that is 150
times less than that we used.
The TiO2 (rutile) particles prepared with HSA were stable
for at least one week, whereas without stabilizer the parti-
cles started to form agglomerates in PBS. Similar results
were obtained for other particles [7].
When nanoparticles get into the circulation they get in
contact first with albumin and other serum proteins.
These proteins cover the nanoparticles and form a protein
corona [18]. Our optimized method uses also albumin or
serum, thus nanoparticles dispersed with our method are
covered with the same proteins nanoparticles encounter
in the circulation.
We found that this optimized method was suitable for
preparing dispersions without coarse agglomerates (aver-
age diameter < 290 nm) from nanosized TiO2 (rutile),
ZnO, Ag, SWNT, MWNT, and diesel SRM2975 particulate
matter. The polydispersity index value was high with
SWNT, MWNT, and SiOx. The interpretation of the size
parameter for nanotubes is different from that of other
particles since nanotubes exhibit a different shape. In this
case, size indicates the hydrodynamic diameter of a spher-
ical particle that would move in the dispersion media with
the same velocity as nanotubes. The high PdI of SWNT
and MWNT nanotubes can also be attributed to the shape
of these particles. In spite of the inaccuracy of the size data
for measurements of nanotubes, dynamic light scattering
gives important information about the agglomeration
state of these dispersions. If nanotubes form agglomerates
they move slower in the dispersion medium and the aver-
age diameter value is bigger than with well-dispersed nan-
otube dispersions. We found such a difference when we
compared the dispersions prepared in PBS with disper-
sions prepared with our optimized method (see Table 1).
For SiOx and TiO2 (anatase) particles, our method was less
effective as indicated by a relatively high average diameter
or PdI of particles. The zeta-potential value in PBS was
always less negative than -30 mV suggesting that the elec-
trostatic repulsive forces play a minor role for stabilization
of these dispersions.
TEM confirmed our findings from dynamic light scatter-
ing as preparation with our optimized method resulted in
an improved dispersion with any of the nanoparticles
measured. The quantitative image analyses of the size of
the TiO2 (rutile) particles yielded similar results to those
from the dynamic light scattering measurements.
Conclusion
We found that the following aspects are important to con-
sider for the preparation of nanoparticle dispersions in
physiological solutions (Fig. 13): i) the optimal sequence
is first to sonicate the nanoparticles in distilled water, than
to add the stabilizer, and finally to add buffered salt solu-
Preparation steps of nanoparticle dispersionFigure 13
Preparation steps of nanoparticle dispersion. 1. Sonicate the nanoparticles in distilled water (power consumption: 7 W, 
1 mL dispersion, 60 sec sonication, = 4.2 × 105 kJ/m3). 2. Add stabilizer (1.5 mg/ml HSA for dispersions with less than 0.2 mg/
ml nanoparticle concentration or serum with a similar albumin concentration). 3. Add PBS to achieve physiological buffer and 
salt concentration.Page 11 of 14
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high enough for deagglomerating the particles (>4.2 × 105
kJ/m3); iii) addition of albumin or serum as stabilizers at
a concentration that is sufficient to cover the nanoparti-
cles (1.5 mg/ml HSA for dispersions with less than 0.2
mg/ml nanoparticle concentration or serum with a similar
albumin concentration).
In conclusion, the optimized dispersion method pre-
sented here appears to be effective and practicable for pre-
paring dispersions of nanoparticles in physiological
solutions without creating coarse agglomerates.
Methods
Materials
Titanium(IV) oxide nanopowder 99.5% rutile ~10 nm ×
40 nm (TiO2 rutile), Titanium(IV) oxide nanopowder
99.7% anatase <25 nm (TiO2 anatase), Zinc oxide nanop-
owder <100 nm (ZnO), 10 × concentrated PBS, 10× con-
centrated RPMI 1640 medium bovine serum albumin
(BSA) and mouse serum albumin (MSA) were purchased
from Sigma-Aldrich, Schnelldorf, Germany. Human
serum albumin (HSA) 50 g/L is from Baxter Deutschland
Gmbh, Heidelberg, Germany. Plain (60 nm), carboxyl
(60 nm) and amine modified polystyrene beads (65 nm)
were purchased from Bangs Laboratories, Fishers, USA. S-
purified single-wall nanotubes, outer diameter <2 nm
length 1–5 μm (SWNT) and s-purified multi-wall nano-
tube, outer diameter 10–30 nm lengths 1–2 μm (MWNT)
are from SES research, Houston, USA. SRM 2975 diesel
particulate matter was purchased by the National Institute
of Standards and Technology, Gaithersburg, USA. Silicon
oxide 99.5%, 10 nm (SiOx) and silver synthesized
99.5+%, 30–50 nm (Ag) were ordered from the Nanos-
tructured and Amorphous Materials Inc, Los Alamos,
USA.
Preparation of mouse serum
C57BL/6NCrl male mice (Charles River, Sulzfeld, Ger-
many) were anesthetized with isoflurane-N2O (FiO2 0.35,
0.015 L/L isoflurane; Forene; Abbott GmbH, Wiesbaden,
Germany). Blood was taken by heart puncture and
allowed to clot. The blood was centrifuged with 5000
RPM for 20 minutes and the supernatant was taken.
Serum samples were pooled and aliquots were stored in -
20°C until use.
Size distribution and zeta-potential measurement
The size distribution and the zeta potential of the nano-
particles were analyzed in aqueous dispersion with a Zeta-
sizer-Nano ZS instrument (Malvern, Malvern Hills,
United Kingdom).
Dynamic light scattering is used by the instrument to
determine the size distribution of particles by measuring
dynamic fluctuations of light scattering intensity caused
by the Brownian motion of the particle. This technique
yields a hydrodynamic diameter that is calculated via the
Stokes-Einstein equation from the aforementioned meas-
urements. The measurement gives as result the average
hydrodynamic diameter of the particles, the peak values
in the hydrodynamic diameter distribution and the poly-
dispersity index (PdI) that describes the width of the par-
ticle size distribution. The PdI scale ranges from 0 to 1,
with 0 being monodisperse and 1 being polydisperse.
Each assigned size and PdI was the mean of 10 subruns.
All measurements were carried out in triplicate with a
temperature equilibration time of 1 minute at 25°C. The
following parameters were used in the instrument settings
to allow for a correct optical model: The Ri(refractive
index) values of the nanoparticles were taken from the lit-
erature. For the dispersant, a Ri of 1.330 and a viscosity of
0.8872 cP were chosen. The data processing mode was set
to high multi-modal resolution.
The measurement technique used by the Zetasizer Nano-
ZS to measure the zeta potential of particles in a solution
is known as phase analysis light scattering. This technique
uses a laser, which is being passed through the sample, to
measure the velocity of the particles in an applied electric
field of a known value. The optical model for the zeta
potential measurements was interpreted by the method of
Smoluchowski since the particles were dispersed in polar
solvents.
Measurement of the effect of different ultrasound energies
A TiO2 (rutile) stock solution was prepared at a concentra-
tion of 0.02 mg/ml in distilled water. One ml of the nan-
oparticle dispersion was sonicated with a Hilscher UP50H
50 watt, 30 kHz sonicator (Hilscher Ultrasonics GmbH,
Teltow, Germany) at different intensities (20%, 50% or
100%) and different durations of sonication (10 sec, 1
min or 5 min). The power consumption of the sonicator
was measured with a power-measuring device during son-
ication of the particles (working operation) and during
sonication of the air (no-load operation). The specific
energy was calculated from the power consumption dif-
ference between working and no-load operation, from the
duration of the sonication, and from the volume of the
dispersion: Espec= (Pwork-Pno-load) × time/volume [16].
Preparation of the particle dispersions
For measuring the accuracy of size and zeta potential
measurement, 60 nm plain, carboxyl and amine modified
particles were prepared at a concentration of 0.02 mg/ml
in distilled water.
To evaluate the different sequences of preparation steps, a
TiO2 (rutile) stock solution was prepared at a concentra-
tion of 0.02 mg/ml in distilled water with or without son-Page 12 of 14
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HSA (end concentration 1.5 mg/ml) or Tween 80 (end
concentration 0.1%) was given to 870 μl of dispersion
before or after the addition of 100 μl of a 10 × concen-
trated PBS solution.
The TiO2 (rutile) dispersion was also prepared in a similar
way using RPMI 1640 cell culture medium and with the
addition of other dispersion stabilizers, i.e. 1.5 mg/ml
mouse serum albumin, 1.5 mg/ml bovine serum albu-
min, 0.1% Tween 80, or 30 μl mouse serum.
The effect of different TiO2 (rutile) and HSA concentra-
tions was tested at TiO2 (rutile) concentrations of 0.002,
0.02, 0.2, 2 mg/ml and HSA concentrations of 0.0015,
0.015, 0.15, 1.5, and15 mg/ml.
The stability of 0.02 mg/ml TiO2 (rutile) dispersions made
by sonication with 4.2 × 105 kJ/m3 energy and addition of
1.5 mg/ml HSA followed by addition of PBS was meas-
ured for 1 week.
Dispersions were also made from TiO2 (anatase), ZnO,
SWNT, MWNT, silver, SiOx, and SRM 2975 diesel nano-
particles by preparing a 0.02 mg/ml stock solution, soni-
cating with 4.2 × 105 kJ/m3 specific ultrasound energy,
adding of 1.5 mg/ml HSA, 0.1% Tween, or 30 μl serum
prior to addition of concentrated PBS.
Transmission electron microscopy
The particles of the dispersions were visualized with a
transmission electron microscope (TEM Jeol JEM 2010)
operated at 200 kV. Samples for TEM analysis were pre-
pared by letting a drop of nanoparticle dispersion dry
onto a holey carbon layer covered copper mesh grid (Agar
Scientific Ltd., Stansted, UK). Mean particle size in the
TiO2 (rutile) dispersion prepared with HSA was analyzed
using Image J software (National Institutes of Health,
Bethesda, USA) by measuring the diameter of 100 parti-
cles.
Statistics
Data analysis was performed with a statistical software
package (SigmaStat for Windows, Jandel Scientific,
Erkrath, Germany). The ANOVA test followed by the Dun-
nett (comparison versus control), Student-Newman-Keuls
(all pair wise comparison) were used for the estimation of
stochastic probability. T-test was used to compare two
groups. Mean values and standard deviation are given. P
values < 0.05 were considered significant.
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